Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Journal of Nanobiotechnology|February 7, 2023
Novel opto-fluidic drug delivery system for efficient cellular transfectionMajid Layachi, Anthony Treizebré, Laurent Hay, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 19, 2004
Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traitsDavid Gilbert, Joseph McClernon, Norka Rabinovich, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of AmericaBrad Spellberg, Robert Guidos, David Gilbert, et al.International Urology and Nephrology|May 8, 2020
Surgical management and outcomes of adult acquired buried penis with and without lichen sclerosus: a comparative analysisM Francesca Monn, Michael Chua, Mélanie Aubé, et al.Open Forum Infectious Diseases|June 8, 2018
Management Practices for Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia by Adult Infectious Diseases PhysiciansNatalie Banniettis, Susan E Beekmann, Philip M Polgreen, et al.Briefings in Bioinformatics|November 23, 2006
Computational methodologies for modelling, analysis and simulation of signalling networksDavid Gilbert, Hendrik Fuss, Xu Gu, et al.Science Signaling|December 24, 2010
The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifierOliver E Sturm, Richard Orton, Joan Grindlay, et al.The Biochemical Journal|June 2, 2011
Variation in the organization and subunit composition of the mammalian pyruvate dehydrogenase complex E2/E3BP core assemblySwetha Vijayakrishnan, Philip Callow, Margaret A Nutley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2009
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trialsBrad Spellberg, George H Talbot, Helen W Boucher, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2008
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaHelen W Boucher, George H Talbot, John S Bradley, et al.Pageof 8